Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Chailease (5871.TW)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (NT$)	Price Target (NT$)	Rating
2023-06-09	198.84	260.83	Buy
2023-08-28	174.05	243.569	Buy
2023-11-09	170.69	233.021	Buy
2024-05-06	165.90	137.127	Sell
2024-05-13	150.55	136.173	Sell
2024-08-28	141.34	125.274	Sell
2024-11-12	127.94	122.549	Sell
2025-01-31	113.24	-	No Rating
2025-02-03	117.65	122.549	Sell
2025-02-26	123.04	107.843	Sell
2025-05-14	122.55	103.922	Sell
2025-11-14	99.51	101.961	Neutral
2026-05-13	105.39	109.80	Neutral

Disclosures

UBS holds a long position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.